Cases 51 - 60 of 132
The State of Montana et al v. Eli Lilly and Company et al
as 2:2023cv04214
In Re:
INSULIN PRICING LITIGATION
Plaintiff:
The State of Montana, Ex. Rel.
Defendant:
ELI LILLY AND COMPANY, NOVO NORDISK INC., SANOFI-AVENTIS U.S. L.L.C. and others
Cause Of Action: 28 U.S.C. § 1442 Notice of Removal
INSULIN PRICING LITIGATION
as 2:2023md03080
In Re:
INSULIN PRICING LITIGATION
Defendant:
EVERNORTH HEALTH INC., ELI LILLY AND COMPANY, NOVO NORDISK INC. and others
Not Classified By Court:
HON. JOSEPH A. DICKSON
Plaintiff:
THE STATE OF MONTANA, EX. REL., THE STATE OF KANSAS EX. REL., TIMOTHY GRIFFIN and others
Cause Of Action: 18 U.S.C. § 1962 Racketeering (RICO) Act
COUNTY OF MONMOUTH, NEW JERSEY v. ELI LILLY AND COMPANY et al
as 3:2023cv03916
Plaintiff:
CITY OF MONMOUTH, NEW JERSEY and COUNTY OF MONMOUTH, NEW JERSEY
Defendant:
ELI LILLY AND COMPANY, NOVO NORDISK INC., SANOFI-AVENTIS U.S. LLC and others
Cause Of Action: 18 U.S.C. § 1961 Racketeering (RICO) Act
JANECEK v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv00538
Plaintiff:
ROBERT L. JANECEK
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HJ HARKINS CO., INC., HUAHAI U.S. INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BIXLER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD et al
as 1:2022cv06653
Plaintiff:
DEBORAH BIXLER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ENANDER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06383
Plaintiff:
MARK ENANDER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MOTTIE v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06304
Plaintiff:
MAURICE MOTTIE
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DIZINNO v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv05325
Plaintiff:
DORIS DIZINNO
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MIRABILE v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv04254
Plaintiff:
CHANTAL MIRABILE
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DUNN v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv04071
Plaintiff:
JAMES C. DUNN and JAMES DUNN
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
